Sandbox:Mitra2: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
<small>
__NOTOC__
{|
{{Xyz}}
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
'''For patient information, click [[Xyz (patient information)|here]]'''
! rowspan="2" |<small>Diseases</small>
 
! colspan="3" |<small>Symptoms</small>
{{CMG}}; {{AE}}
! colspan="3" |<small>Physical Examination</small>
 
! colspan="4" |<small>Diagnostic tests
{{SK}}
! rowspan="2" |<small>Other Findings</small>
 
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
==[[Xyz overview|Overview]]==
!<small>Dyspnea on Exertion</small>
 
!<small>Chest Pain</small>
==[[Xyz historical perspective|Historical Perspective]]==
!<small>Hemoptysis</small>
 
!<small>Fever</small>
==[[Xyz classification|Classification]]==
!<small>Tachypnea</small>
 
!<small>Tachycardia</small>
==[[Xyz pathophysiology|Pathophysiology]]==
!<small>Chest X-ray</small> 
 
!<small>ECG</small>
==[[Xyz causes|Causes]]==
!<small>Echocardiography>
 
!<small>CT scan and CMRI</small>
==[[Xyz differential diagnosis|Differentiating Xyz from other Diseases]]==
|-
 
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]]
==[[Xyz epidemiology and demographics|Epidemiology and Demographics]]==
| style="background: #F5F5F5; padding: 5px;" |✔
 
| style="background: #F5F5F5; padding: 5px;" |-
==[[Xyz risk factors|Risk Factors]]==
| style="background: #F5F5F5; padding: 5px;" |✔
 
| style="background: #F5F5F5; padding: 5px;" |-
==[[xyz screening|Screening]]==
| style="background: #F5F5F5; padding: 5px;" |✔
 
| style="background: #F5F5F5; padding: 5px;" |✔
==[[Xyz natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
| style="background: #F5F5F5; padding: 5px;" |
 
*[[Cardiomegaly]]
==Diagnosis==
*[[Pulmonary edema]] (interstitial, alveolar)
[[Xyz diagnostic study of choice|Diagnostic study of choice]] | [[Xyz history and symptoms|History and Symptoms]] | [[Xyz physical examination|Physical Examination]] | [[Xyz laboratory findings|Laboratory Findings]] | [[Xyz electrocardiogram|Electrocardiogram]] | [[Xyz x ray|X-Ray Findings]] | [[Xyz echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Xyz CT scan|CT-Scan Findings]] | [[Xyz MRI|MRI Findings]] | [[Xyz other imaging findings|Other Imaging Findings]] | [[Xyz other diagnostic studies|Other Diagnostic Studies]]
| style="background: #F5F5F5; padding: 5px;" |
 
*[[Left ventricular hypertrophy]]
==Treatment==
*[[Low-voltage]] QRS
[[Xyz medical therapy|Medical Therapy]] | [[Xyz interventions|Interventions]] | [[Xyz surgery|Surgery]] | [[Xyz primary prevention|Primary Prevention]] | [[Xyz secondary prevention|Secondary Prevention]] | [[Xyz cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Xyz future or investigational therapies|Future or Investigational Therapies]]
*Non-specific ST-T change
 
| style="background: #F5F5F5; padding: 5px;" |
==Case Studies==
*Systoloic dysfunction (in HFrEF)
[[Xyz case study one|Case #1]]
*Diastoic dysfunction (in HFpEF)
 
*[[COVID-19-associated stress cardiomyopathy|COVID-19-associated stress cardiomyopathy]] [[(apical ballooning)]]
[[Category: (name of the system)]]
| style="background: #F5F5F5; padding: 5px;" |
*CT: [[Cardiomegaly]], [[Pulmonary edema]]
*CMR: Signs of underlying [[myocarditis]] may be seen.
| style="background: #F5F5F5; padding: 5px;" | Increased [[NT-proBNP]] and cardiac [[troponin]]s levels
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pneumonia]]
| style="background: #F5F5F5; padding: 5px;" |✔ (Usually high)
| style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleuritic]])
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Lobar Consalidation]]
| style="background: #F5F5F5; padding: 5px;" |
*Prolonged PR interval
*Transient T wave inversions
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
*CT: [[Lobar Consalidation]]
| style="background: #F5F5F5; padding: 5px;" | Increased inflammatory markers, including [[ESR]], [[hs-CRP]]
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated acute respiratory distress syndrome|COVID-19-associated acute respiratory distress syndrome
]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*Bilateral [[ground-glass opacities]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
*Signs of RV dysfunction/RV dilatation may be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CT: Bilateral [[ground-glass opacities]]
| style="background: #F5F5F5; padding: 5px;" | -
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Pericardial effusion]] may be detectable
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays)
| style="background: #F5F5F5; padding: 5px;" |
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen.
*[[Pericardial effusion]] may be be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "[[Late gadolinium enhancement (LGE)]] imaging” can demonstrate myocardial damage.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]]s level
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]]
| style="background: #F5F5F5; padding: 5px;" |✔ (Usually sudden-onset)
| style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleauritic]])
| style="background: #F5F5F5; padding: 5px;" |✔ (If massive PE)
| style="background: #F5F5F5; padding: 5px;" |✔ (Low-grade)
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*May show [[Fleischner sign]] (enlarged pulmonary artery), [[Hampton hump]], [[Westermark's sign]]
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show [[S1Q3T3]] pattern
| style="background: #F5F5F5; padding: 5px;" |  
*May show signs of RV strain, Rv dilatation, Rv dysfunction (if large PE)
| style="background: #F5F5F5; padding: 5px;" |
*On CT angiography: Intra-luminal filling defect
*On MRI: Narrowing of involved vessel
*No contrast seen distal to obstruction
*Polo-mint sign (partial filling defect surrounded by contrast)
| style="background: #F5F5F5; padding: 5px;" |
*Increased [[D-dimer]], [[fibrinogen]], and [[fibrin degradation products]] levels
*May have symptoms and/or signs of accompanying [[DVT]]

Latest revision as of 10:28, 13 August 2021

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox:Mitra2 On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox:Mitra2

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox:Mitra2

CDC on Sandbox:Mitra2

Sandbox:Mitra2 in the news

Blogs on Sandbox:Mitra2

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sandbox:Mitra2

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1